Clinical TrialsBayer Reports Positive Phase III FIND-CKD Results for Finerenone Bayer Reports Positive Phase III FIND-CKD Results for Finerenone Read Post »
New Drug ApprovalAstraZeneca’s Imfinzi Combo Approved in EU for Gastric Cancer AstraZeneca’s Imfinzi Combo Approved in EU for Gastric Cancer Read Post »
Clinical TrialsFDA Allows U.S. Enrollment in BioVersys Phase 3 Trial of BV100 for Drug-Res... FDA Allows U.S. Enrollment in BioVersys Phase 3 Trial of BV100 for Drug-Res... Read Post »
Clinical TrialsNRx Targets FDA Approval for NRX-100 in Severe Depression NRx Targets FDA Approval for NRX-100 in Severe Depression Read Post »
Clinical TrialsAbbott’s Libre CGM Improves HbA1c and Time-in-Range in FreeDM2 Trial Abbott’s Libre CGM Improves HbA1c and Time-in-Range in FreeDM2 Trial Read Post »
New Drug ApprovalChina Approves Zydus’ Desidustat for Renal Anaemia in Chronic Kidney Dise... China Approves Zydus’ Desidustat for Renal Anaemia in Chronic Kidney Dise... Read Post »
New Drug ApprovalFDA Broadens Use of GSK’s Arexvy to At-Risk Adults 18–49 FDA Broadens Use of GSK’s Arexvy to At-Risk Adults 18–49 Read Post »
New Drug ApprovalCosentyx Becomes First IL-17A Inhibitor Approved for Adolescents in Hidrade... Cosentyx Becomes First IL-17A Inhibitor Approved for Adolescents in Hidrade... Read Post »
Clinical TrialsOtsuka’s Repinatrabit Cuts Blood Phe 67% in Adolescents with PKU Otsuka’s Repinatrabit Cuts Blood Phe 67% in Adolescents with PKU Read Post »
Clinical TrialsUnited’s Tyvaso Delivers Positive Phase 3 Results in IPF United’s Tyvaso Delivers Positive Phase 3 Results in IPF Read Post »
Drugs Safety AlertLilly Warns Compounded Tirzepatide Mixed with B12 May Pose Risks Lilly Warns Compounded Tirzepatide Mixed with B12 May Pose Risks Read Post »
Drugs Safety Alert Health TidingsFDA Rolls Out AEMS Safety Dashboard, Saving $120M FDA Rolls Out AEMS Safety Dashboard, Saving $120M Read Post »
New Drug ApprovalFDA Approves Johnson & Johnson’s TECNIS PureSee IOL for Cataract Surg... FDA Approves Johnson & Johnson’s TECNIS PureSee IOL for Cataract Surg... Read Post »
Clinical TrialsCapricor Reports New HOPE-3 Data Showing Deramiocel Improves Cardiac and Fu... Capricor Reports New HOPE-3 Data Showing Deramiocel Improves Cardiac and Fu... Read Post »
Clinical TrialsBridgeBio Unveils Strong Phase 3 Interim Data for BBP-418 in LGMD2I/R9 at M... BridgeBio Unveils Strong Phase 3 Interim Data for BBP-418 in LGMD2I/R9 at M... Read Post »
Clinical TrialsBioMarin Presents New VOXZOGO Data Supporting Early Treatment in Achondropl... BioMarin Presents New VOXZOGO Data Supporting Early Treatment in Achondropl... Read Post »
Clinical TrialsBiogen Initiates Phase 3 Program for Salanersen Following Promising Phase 1... Biogen Initiates Phase 3 Program for Salanersen Following Promising Phase 1... Read Post »
New Drug ApprovalJ&J’s Niraparib–Abiraterone Combo Approved in EU for BRCA-Mutated m... J&J’s Niraparib–Abiraterone Combo Approved in EU for BRCA-Mutated m... Read Post »
New Drug ApprovalEuropean Commission Approves Every-4-Week Dosing of Pegunigalsidase Alfa fo... European Commission Approves Every-4-Week Dosing of Pegunigalsidase Alfa fo... Read Post »
Clinical TrialsAscletis’ GLP-1 ASC30 Depot Injection Achieves Promising Phase 2 Results ... Ascletis’ GLP-1 ASC30 Depot Injection Achieves Promising Phase 2 Results ... Read Post »
Drugs Safety AlertFDA Issues Warning Letter to Novo Nordisk Over Pharmacovigilance Deficienci... FDA Issues Warning Letter to Novo Nordisk Over Pharmacovigilance Deficienci... Read Post »
Clinical TrialsTelix Reports Positive Safety Results from Phase 3 ProstACT Global Trial of... Telix Reports Positive Safety Results from Phase 3 ProstACT Global Trial of... Read Post »
Clinical TrialsVertex’s Povetacicept Cuts Proteinuria by 52% in Phase 3 RAINIER Interim ... Vertex’s Povetacicept Cuts Proteinuria by 52% in Phase 3 RAINIER Interim ... Read Post »
New Drug ApprovalFDA Approves Wellcovorin (Leucovorin Calcium) as First Treatment for Rare F... FDA Approves Wellcovorin (Leucovorin Calcium) as First Treatment for Rare F... Read Post »
Drugs Safety AlertIpsen Withdraws Tazverik After SYMPHONY-1 Trial Flags Secondary Blood Cance... Ipsen Withdraws Tazverik After SYMPHONY-1 Trial Flags Secondary Blood Cance... Read Post »
Clinical TrialsAbbVie Reports Up to 9.8% Weight Loss in Phase 1 MAD Trial of Long-Acting A... AbbVie Reports Up to 9.8% Weight Loss in Phase 1 MAD Trial of Long-Acting A... Read Post »
Clinical TrialsRegeneron, Hansoh Report 19.3% Weight Loss with Dual GLP-1/GIP Drug Olatore... Regeneron, Hansoh Report 19.3% Weight Loss with Dual GLP-1/GIP Drug Olatore... Read Post »
Clinical TrialsPfizer’s Trispecific Antibody Tilrekimig Shows Positive Phase 2 Results i... Pfizer’s Trispecific Antibody Tilrekimig Shows Positive Phase 2 Results i... Read Post »
Clinical TrialsRoche Reports Phase 3 persevERA Setback for Giredestrant in Breast Cancer Roche Reports Phase 3 persevERA Setback for Giredestrant in Breast Cancer Read Post »
Clinical TrialsImmunityBio Files Updated ANKTIVA sBLA with FDA for Papillary NMIBC ImmunityBio Files Updated ANKTIVA sBLA with FDA for Papillary NMIBC Read Post »
New Drug ApprovalFDA Approves PYLARIFY TruVu for PSMA PET Imaging in Prostate Cancer FDA Approves PYLARIFY TruVu for PSMA PET Imaging in Prostate Cancer Read Post »
New Drug ApprovalEuropean Commission Approves Incyte’s Zynyz Combination Therapy for First... European Commission Approves Incyte’s Zynyz Combination Therapy for First... Read Post »
Clinical TrialsJOURNAVX Demonstrates High Opioid-Free Recovery Rate in Phase 4 Study JOURNAVX Demonstrates High Opioid-Free Recovery Rate in Phase 4 Study Read Post »
Clinical TrialsHelus Pharma Reports Positive Phase 2 Results for HLP004 in GAD Helus Pharma Reports Positive Phase 2 Results for HLP004 in GAD Read Post »
New Drug ApprovalFDA Approves Bristol Myers Squibb’s Sotyktu as First TYK2 Inhibitor for A... FDA Approves Bristol Myers Squibb’s Sotyktu as First TYK2 Inhibitor for A... Read Post »
Clinical TrialsRoche’s Gazyva Shows Strong Phase III Success in Systemic Lupus: ALLEGORY... Roche’s Gazyva Shows Strong Phase III Success in Systemic Lupus: ALLEGORY... Read Post »
Clinical TrialsRoche’s Amylin Analog Petrelintide Delivers Up to 10.7% Weight Loss in Ph... Roche’s Amylin Analog Petrelintide Delivers Up to 10.7% Weight Loss in Ph... Read Post »
Clinical TrialsFDA Places Partial Clinical Hold on PepGen’s FREEDOM2-DM1 Trial of PGN-ED... FDA Places Partial Clinical Hold on PepGen’s FREEDOM2-DM1 Trial of PGN-ED... Read Post »
ResearchGLP-1 Weight Loss Is Driving New Demand for Facial Aesthetic Treatments, Al... GLP-1 Weight Loss Is Driving New Demand for Facial Aesthetic Treatments, Al... Read Post »
Clinical TrialsFibroBiologics Nears Trial Initiation for CYWC628 in Diabetic Foot Ulcers FibroBiologics Nears Trial Initiation for CYWC628 in Diabetic Foot Ulcers Read Post »
New Drug ApprovalJ&J’s TECVAYLI–DARZALEX FASPRO Combo Wins FDA Approval After MajesT... J&J’s TECVAYLI–DARZALEX FASPRO Combo Wins FDA Approval After MajesT... Read Post »
Clinical TrialsBiogen and Stoke Therapeutics Report Up to 91% Seizure Reduction with Zorev... Biogen and Stoke Therapeutics Report Up to 91% Seizure Reduction with Zorev... Read Post »
New Drug ApprovalGlenmark Secures FDA Approval and CGT Exclusivity for Generic Fluticasone Glenmark Secures FDA Approval and CGT Exclusivity for Generic Fluticasone Read Post »
Clinical TrialsAmpreloxetine Misses Primary Endpoint in MSA-nOH CYPRESS Trial, Triggers Sa... Ampreloxetine Misses Primary Endpoint in MSA-nOH CYPRESS Trial, Triggers Sa... Read Post »
New Drug ApprovalAgios’ PYRUKYND Gains UAE Approval as First Therapy for Thalassemia P... Agios’ PYRUKYND Gains UAE Approval as First Therapy for Thalassemia P... Read Post »
Drugs Safety AlertKyowa Kirin Discontinues All Rocatinlimab Trials Over Emerging Malignancy R... Kyowa Kirin Discontinues All Rocatinlimab Trials Over Emerging Malignancy R... Read Post »
Clinical TrialsIntellia Unveils Striking Long-Term Data on CRISPR Therapy Lonvo-z for Here... Intellia Unveils Striking Long-Term Data on CRISPR Therapy Lonvo-z for Here... Read Post »
Clinical TrialsMerck, Eisai Advance Dual Oral Therapy with Strong Phase 3 RCC Data at ASCO... Merck, Eisai Advance Dual Oral Therapy with Strong Phase 3 RCC Data at ASCO... Read Post »
Clinical Trials55% Risk Reduction: Ralinepag’s ADVANCE OUTCOMES Results Signal New P... 55% Risk Reduction: Ralinepag’s ADVANCE OUTCOMES Results Signal New P... Read Post »
New Drug ApprovalHERNEXEOS® Gains FDA Nod as First-Line Option for HER2-Mutant NSCLC HERNEXEOS® Gains FDA Nod as First-Line Option for HER2-Mutant NSCLC Read Post »
